Abstract

Atomoxetine 4-mg/mL Oral Solution/Suspension

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2021 - Volume 25, Number 4

Page(s): 321

Download in electronic PDF format for $75
  • Atomoxetine 4-mg/mL Oral Solution/Suspension Page 1

Abstract

A formulation for preparing Atomoxetine 4-mg/mL Oral Solution/Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • atomoxetine hydrochloride
  • oral solution
  • oral suspension
  • selective norepinephrine reuptake inhibitor
  • attention deficit hyperactivity disorder
  • ADHD

Related Categories

  • FORMULATIONS
  • MENTAL HEALTH
  • PEDIATRICS
  • DOSAGE FORMS/DRUG CARRIERS
  • NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2021
Pg. 321
Atomoxetine 4-mg/mL Oral Solution/Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 1997
Pg. 87-89
Attention Deficit Hyperactivity Disorder
Author(s): Allen Loyd V Jr
Jan/Feb 2004
Pg. 46-48
Basics of Compounding for Disorders of the External Ear
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Jan/Feb 2001
Pg. 21-22
Methylphenidate in the Treatment of Attention Deficit Disorders
Author(s): Tenreiro Kim
Jan/Feb 2004
Pg. 10-14
Women's Oral Health: Is There a Hormonal Link?
Author(s): Preckshot John
Nov/Dec 2021
Pg. 505
Pyridoxine Hydrochloride 25 mg/mL in Oral Mix and Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2023
Pg. 58-59
Suspension Solution, Sugar Free
Author(s): Allen Loyd V Jr
Mar/Apr 2016
Pg. 155-158
Utilization of Compounded Medications in an Oral Medicine Practice
Author(s): Stock Shannon, Rubino Katie, Woo Sook-Bon, Margolis Arthur, Thomas Irena, Aboalela Ali, Treister Nathaniel
Jan/Feb 2001
Pg. 6-8
Pediatric Compounding: Coloring Outside the Lines
Author(s): Preckshot John
Mar/Apr 2011
Pg. 124-128
Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease
Author(s): Corsini Lindsay, Williams LaVonn A
Sep/Oct 2023
Pg. 420
Nitazoxanide 20-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2011
Pg. 340
Methylprednisolone 4-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2018
Pg. 66-75
Stability of an Alcohol-free, Dye-free Hydrocortisone (2 mg/mL) Compounded Oral Suspension
Author(s): Manchanda Arushi, Laracy Melissa, Savji Taslim, Bogner Robin H
Nov/Dec 2017
Pg. 481-486
Basics of Compounding: Compounding Irrigation Solutions for Sterile and Nonsterile Preparations
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 415
Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 416
Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2021
Pg. 420
Sorafenib 20-mg/mL in Oil Oral Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2021
Pg. 44
Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2021
Pg. 47
Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension
Author(s): Allen Loyd V Jr